Treatment with inhaled corticosteroids in COPD groups GOLD A and B –relationship to clinical state in the COSYCONET cohort
K. Kahnert (Munich, Germany), R. Jörres (Munich, Germany), F. Trudzinski (Heidelberg, Germany), P. Alter (Marburg, Germany), C. Kellerer (Munich, Germany), H. Watz (grosshansdorf, Germany), T. Welte (Hannover, Germany), R. Bals (Homburg, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Behr (Munich, Germany), R. Holle (Munich, Germany), C. Vogelmeier (Munich, Germany), J. Lutter (Munich, Germany)
Source: Virtual Congress 2021 – Treatments for airway diseases
Session: Treatments for airway diseases
Session type: E-poster
Number: 1836
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kahnert (Munich, Germany), R. Jörres (Munich, Germany), F. Trudzinski (Heidelberg, Germany), P. Alter (Marburg, Germany), C. Kellerer (Munich, Germany), H. Watz (grosshansdorf, Germany), T. Welte (Hannover, Germany), R. Bals (Homburg, Germany), D. Kauffmann-Guerrero (Munich, Germany), J. Behr (Munich, Germany), R. Holle (Munich, Germany), C. Vogelmeier (Munich, Germany), J. Lutter (Munich, Germany). Treatment with inhaled corticosteroids in COPD groups GOLD A and B –relationship to clinical state in the COSYCONET cohort. 1836
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: